Since previous studies showed a reduction in vaccine-induced immune responses in patients on anti-TNF therapy compared to those on therapy with other cellular targets (non-anti-TNF), we stratified antibody responses by IBD therapy [7,10]. The gene discussed is TNF; the disease is inflammatory bowel disease.